An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

BACKGROUND: Since treatment with immune checkpoint inhibitors (ICIs) is becoming standard therapy for patients with high-risk and advanced melanoma, an increasing number of patients experience treatment-related adverse events such as fatigue. Until now, studies have demonstrated the benefits of usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fraterman, Itske, Wollersheim, Barbara M, Tibollo, Valentina, Glaser, Savannah Lucia Catherina, Medlock, Stephanie, Cornet, Ronald, Gabetta, Matteo, Gisko, Vitali, Barkan, Ella, di Flora, Nicola, Glasspool, David, Kogan, Alexandra, Lanzola, Giordano, Leizer, Roy, Mallo, Henk, Ottaviano, Manuel, Peleg, Mor, van de Poll-Franse, Lonneke V, Veggiotti, Nicole, Śniatała, Konrad, Wilk, Szymon, Parimbelli, Enea, Quaglini, Silvana, Rizzo, Mimma, Locati, Laura Deborah, Boekhout, Annelies, Sacchi, Lucia, Wilgenhof, Sofie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600650/
https://www.ncbi.nlm.nih.gov/pubmed/37819691
http://dx.doi.org/10.2196/49252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600650/
https://www.ncbi.nlm.nih.gov/pubmed/37819691
http://dx.doi.org/10.2196/49252

Ejemplares similares